Current conservative management of Osteoarthritis, lack of DMAODs, and failure to translate past clinical trial stage
Current conservative management of Osteoarthritis, lack of DMAODs, and failure to translate past clinical trial stage
Created using ChatSlide
This research explores the management of osteoarthritis (OA), addressing symptom-modifying drugs and existing disease management options. It highlights the absence of disease-modifying drugs, reflecting on the challenges in drug development, including the frequent failure of novel therapies in clinical trials and the significant financial investments yielding limited progress.